Tickerplace logo

Tickerplace

Myriad Genetics, Inc. logo

MYGNMyriad Genetics, Inc.

MYGN Stock Price, Valuation & Chart | Myriad Genetics, Inc.

Compare
$3.980-0.37 (-8.51%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Diagnostics & Research
OverviewFinancialsDividendsRatios

MYGN Historical price chart

MYGN Key Stats

Market Capitalization380.69M
PE Ratio-30.62
EPS-0.13
Trading Volume1.42M
Today's High/Low4.31/3.97
Dividend Yield0.00
52 Week High/Low8.5/2.74
Shares Outstanding95.65M
MYGN Financial Statement
MYGN Analyst ratings
MYGN Analysis & performance metrics

MYGN Company profile

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company…

MYGN Management team

Management
Mark S. VerrattiCOO
Chief Operating Officer
Matthew Scalo
Senior Vice President of Investor Relations
Jennifer L. Fox J.D.
Chief Legal Officer
Natalie Munk
Senior Vice President & Chief Accounting Officer
Paul J. Diaz J.D.CTO
Consultant & Director
Scott J. LefflerCFO
Chief Financial Officer
Samraat S. RahaCEO
President, Chief Executive Officer & Director
Shereen Solaiman
Chief People Officer
Total 8 executives

MYGN Frequently asked questions

What is Myriad Genetics, Inc. (MYGN) Stock Price?

Current stock price of Myriad Genetics, Inc. (MYGN) stock is $3.980. The stock price is -8.51% lower in the session. The intraday range can be seen from this page. Volume of Myriad Genetics, Inc. (MYGN) stock is 1.42M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Myriad Genetics, Inc. (MYGN) stock price going up or down today?

The stock price of Myriad Genetics, Inc. (MYGN) can change with earnings, company news, and overall market sentiment. Myriad Genetics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Myriad Genetics, Inc. stock expensive at its current price?

Whether Myriad Genetics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MYGN on this page is -30.62. EPS on this page is -0.13. Compare those figures with peers and growth expectations before deciding if the current Myriad Genetics, Inc. price is justified.

How has the stock price of Myriad Genetics, Inc. (MYGN) performed historically?

Historical performance for Myriad Genetics, Inc. (MYGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MYGN reacted to past earnings and market events.

Should I buy Myriad Genetics, Inc. (MYGN) stock, at this price?

Buying Myriad Genetics, Inc. (MYGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.